These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37152788)

  • 1. Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Trivedi S; Lam K; Ganesh A; Hasnain Y; Hassan W; Herren J; Gaba RC
    Semin Intervent Radiol; 2023 Feb; 40(1):9-14. PubMed ID: 37152788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.
    Praktiknjo M; Abu-Omar J; Chang J; Thomas D; Jansen C; Kupczyk P; Schepis F; Garcia-Pagan JC; Merli M; Meyer C; Strassburg CP; Pieper CC; Trebicka J
    JHEP Rep; 2021 Jun; 3(3):100264. PubMed ID: 34013182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory hepatic encephalopathy due to concomitant transjugular intrahepatic portosystemic shunt and spontaneous mesocaval shunt controlled by embolization of the competitive portosystemic shunt.
    Cura M
    Clin Imaging; 2009; 33(3):231-3. PubMed ID: 19411031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate.
    Nardelli S; Bellafante D; Ridola L; Faccioli J; Riggio O; Gioia S
    Metab Brain Dis; 2023 Jun; 38(5):1729-1736. PubMed ID: 36445629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Spontaneous Portosystemic Shunt Embolization and Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Hepatic Encephalopathy.
    Gurtatta RS; Gaba RC; Herren JL
    J Vasc Interv Radiol; 2024 May; 35(5):659-663. PubMed ID: 38355039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
    Horhat A; Bureau C; Thabut D; Rudler M
    United European Gastroenterol J; 2021 Mar; 9(2):203-208. PubMed ID: 32819214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
    Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
    Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Kloster ML; Ren A; Shah KY; Alqadi MM; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
    Dig Dis Sci; 2021 Nov; 66(11):4058-4062. PubMed ID: 33236314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study.
    Wang HL; Lu WJ; Zhang YL; Nie CH; Zhou TY; Zhou GH; Zhu TY; Wang BQ; Chen SQ; Yu ZN; Jing L; Sun JH
    Front Med (Lausanne); 2021; 8():737984. PubMed ID: 34671621
    [No Abstract]   [Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of recurrent severe hepatic encephalopathy in patients with large porto-collaterals shunts or transjugular portosystemic shunt.
    Temmerman F; Laleman W; Maleux G; Nevens F
    Acta Gastroenterol Belg; 2020; 83(1):67-71. PubMed ID: 32233274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
    Luo SH; Zhou MM; Cai MJ; Han SL; Zhang XQ; Chu JG
    World J Gastroenterol; 2023 Apr; 29(15):2336-2348. PubMed ID: 37124886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
    United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
    Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
    World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.